Antidepressant Medications
Name | Indication, starting dose, target symptoms, and affected neurotransmitters | Half-life (T1/2) CYP450 enzyme | Notes/Notable side effects/Precautions |
SSRIs | |||
Citalopram (Celexa) | |||
Escitalopram (Lexapro) | |||
Fluoxetine (Prozac) | |||
Fluvoxamine (Luvox) | |||
Paroxetine (Paxil) | |||
Sertraline (Zoloft) | |||
SNRIs | |||
Venlafaxine (Effexor) | |||
Desvenlafaxine (Pristiq) | |||
Duloxetine (Cymbalta) | |||
Other | |||
Mirtazapine (Remeron) | |||
Trazadone (Desyrel) | |||
Vilazodone (Viibryd) | |||
Vortioxetine (Trintellix) | |||
Bupropion (Wellbutrin) |
This table includes the most commonly prescribed medications for depression. If there are other medications you would like to include for your reference you can add rows.
Mood Stabilizer Medications
Name | Indication (FDA approval )& Starting dose | Half-life (T1/2) CYP450 enzyme | Notes/notable side effects/precautions/required diagnostics/therapeutic levels |
Lithium |
|
|
|
Carbamazepine (Tegretol) |
|
|
|
Valproic Acid |
|
|
|
Lamotrigine (Lamictal) |
|
|
|
This table focuses on the 4 medications mentioned in your Stahl (2021) textbook. You may add others you think are pertinent.
Instructions:
For each medication listed, complete the following:
a. Provide indication, starting dose target symptoms, and affected neurotransmitters.
b. Include half-life and CYP 450 enzyme information.
c. List notable side effects and precautions.
d. Link notable side effects to the associated pathway or neurotransmitter.
2. 4 APA references needed with intext citation. Scholarly references must be within 5 years. For each medication listed, complete the following:
1. Provide indication, starting dose target symptoms, and affected neurotransmitters.
2. Include half-life and CYP 450 enzyme information.
3. List notable side effects and precautions
4. Link notable side effects to the associated pathway or neurotransmitter.